TSS:Rfhg 229781.1

Basic information about the TSS

---

TSS ID: rfhg_229781.1 TSS ID(Version3): hg_193951.1 hg_193952.1 hg_193950.1 Species: human Chr: chr22		Start: 36481370 End: 36481662 Strand: -
Source datasets	FANTOM5|PRJDB5282|PRJNA615891|PRJNA548673|PRJNA597322 |PRJNA4843412|DRA013844|PRJNA401781
Protocol	CAGE|C1CAGE|SLIC_CAGE|STRIPE-seq|NETCAGE|RAMPAGE |oligo_capping|ReCappable-seq|TIF-seq2
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3368993,EH38E2161915)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000416967.1:0 ENST00000216185.7:0 ENST00000487725.1:0 ENST00000411915.1:0 AK130187:0 AF480262:0 BC013726:0 BC050610:0 GeneID: 25828 HGNC/MGI_ID: HGNC:17772 UniProt_ID: F8WDN2 M0QXH0 Q99757 Nearer transcript ids and distances:

Gene_name: TXN2 Gene_symbol: TXN2 Gene_synonyms: MT-TRX Gene_source: HGNC:17772

TATA-Box annotation

---

Distance to TSS:	124
Nearest PromoterID:	NM_012473
Entrez ID:	25828
Nearest Unigene:	Hs.211929
Nearest Refseq:	NM_012473
Nearest Ensembl:	ENSG00000100348
Gene Name:	TXN2
Gene Alias:	COXPD29|MT-TRX|MTRX|TRX2|TXN
Gene Type:	protein-coding
CpG%:	0.075342
GC%:	0.651877
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TXN2 p2@TXN2 p3@TXN2 p4@TXN2 p5@TXN2
Sample		p1@TXN2	p2@TXN2	p3@TXN2	p4@TXN2	p5@TXN2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	44.61	1.75	1.56	0.58	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	35.81	1.62	1.21	0.40	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	40.51	3.09	1.16	0.58	2.89
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	29.94	2.08	0.42	2.08	2.70
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	31.05	1.12	1.35	1.12	2.70
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	32.37	2.52	1.94	0.97	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	53.16	5.45	2.18	3.05	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	46.75	1.70	4.36	2.18	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	45.31	2.78	2.35	2.14	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	46.95	2.32	5.22	4.64	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	47.30	2.02	2.02	1.21	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	37.40	2.44	4.07	2.44	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	57.38	6.77	4.67	0.81	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	44.20	5.71	4.06	0.30	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	44.79	5.49	3.51	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	45.02	6.04	4.78	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	36.91	6.77	3.71	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	31.64	8.44	5.48	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	37.32	12.26	3.20	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	62.73	4.36	3.91	0.45	1.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	48.65	6.01	3.88	0.94	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	53.86	6.39	4.32	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	43.30	6.72	3.36	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	40.04	6.31	1.46	0.49	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	39.99	7.22	3.87	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	30.39	7.91	3.48	0.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	38.46	6.59	2.75	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	54.46	4.01	4.48	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	42.97	4.20	3.07	0.48	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	54.65	4.89	4.52	0.00	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	47.10	6.28	4.19	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	50.80	5.47	2.93	0.39	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	36.09	7.81	3.38	0.42	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	50.31	8.08	3.96	0.49	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	60.96	5.61	3.37	0.56	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	54.61	4.60	3.07	0.19	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	56.00	6.54	2.04	0.20	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	49.16	3.43	2.82	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	59.15	5.67	2.70	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	49.69	4.80	2.40	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	46.35	5.65	4.23	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	44.36	6.73	3.81	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	66.01	5.91	3.37	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	54.20	5.07	4.20	0.70	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	72.08	4.42	5.22	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	67.00	5.58	4.19	0.70	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	60.22	4.32	4.56	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	59.61	2.98	2.68	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	51.47	4.55	2.87	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	53.78	5.05	3.44	0.40	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	70.30	4.30	4.30	0.20	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	64.04	4.00	4.23	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	56.78	6.39	1.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	68.60	6.96	3.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	29.36	3.36	6.71	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	59.24	8.27	3.21	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	71.95	3.24	2.59	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	67.12	4.82	3.85	0.32	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	69.15	6.29	5.34	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	46.53	2.82	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	44.86	2.80	1.12	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	47.77	5.57	7.17	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	50.63	3.74	3.74	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	74.73	3.57	1.95	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	39.76	1.42	2.48	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	39.98	0.00	1.95	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	35.70	2.98	3.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	36.59	2.35	1.88	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	39.41	2.32	1.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	48.26	1.55	1.24	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	47.39	1.83	1.53	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	34.21	2.53	2.53	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	57.75	0.48	0.64	1.28	0.48
Adipocyte - omental, donor1	11473-119C6	38.80	3.18	1.91	0.38	0.13
Adipocyte - omental, donor2	11474-119C7	57.56	3.74	0.75	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	53.59	1.00	1.34	0.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	44.02	1.91	3.83	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	48.38	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	43.36	4.06	4.06	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	115.04	3.13	2.95	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	40.68	3.13	2.54	0.39	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	28.31	2.06	1.54	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	36.80	1.39	1.39	1.95	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	40.56	1.76	1.18	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	73.11	1.53	1.05	0.80	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	58.10	1.94	2.58	1.61	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	43.72	1.07	1.60	0.53	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	52.86	0.00	1.67	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	101.89	0.83	0.42	4.16	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	55.76	2.76	0.75	0.75	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	66.10	1.31	1.64	3.27	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	68.51	1.22	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	78.90	0.44	0.66	0.00	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	157.78	2.15	1.08	3.94	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	53.91	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	47.32	1.80	1.26	0.72	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	87.02	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	51.36	0.62	1.44	2.05	0.62
Anulus Pulposus Cell, donor1	11248-116E6	66.14	5.49	1.72	0.92	0.11
Anulus Pulposus Cell, donor2	11463-119B5	83.51	0.73	0.98	1.71	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	49.42	2.25	1.35	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	49.06	0.87	0.87	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	38.52	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	39.46	0.90	0.60	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	48.06	1.26	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	43.56	1.32	0.66	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	39.31	3.25	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	40.29	0.97	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	39.79	2.38	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	43.69	0.00	1.13	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	32.66	2.18	2.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	30.09	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	42.34	0.82	0.99	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	38.21	0.00	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.61	1.36	1.06	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	47.15	2.14	1.07	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	38.92	0.57	1.13	0.57	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	42.77	0.53	0.53	0.27	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	50.72	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	43.95	0.66	0.33	0.17	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	1.20	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	53.10	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	39.45	1.03	0.51	0.00	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	58.73	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	37.38	0.97	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	44.40	1.90	0.76	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	44.82	1.21	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	39.90	1.71	1.71	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	39.98	1.07	0.43	0.21	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	44.39	0.52	0.26	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	35.19	0.94	0.47	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	37.62	0.32	0.32	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	40.67	0.71	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	32.76	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	44.26	0.60	0.30	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	41.58	2.38	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	46.79	1.02	1.02	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	46.86	1.27	0.25	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	36.22	1.27	0.64	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	33.23	0.00	0.00	0.00	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	43.82	1.27	0.64	0.21	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	36.83	1.74	1.16	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	35.90	0.94	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	37.80	1.02	1.19	0.00	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	64.86	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	35.81	0.43	0.86	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	32.49	1.80	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	41.55	0.00	0.73	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	45.52	1.61	0.69	0.23	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	37.63	1.02	0.76	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	38.40	1.24	0.41	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	35.19	1.84	0.61	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	46.85	0.00	1.91	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	43.02	0.89	0.44	0.00	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	38.14	3.05	7.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	33.79	1.11	1.11	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	39.45	0.79	0.53	0.26	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	38.89	0.36	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	113.85	3.56	3.44	1.84	0.86
Astrocyte - cerebellum, donor2	11580-120F5	136.41	1.37	0.68	4.11	0.00
Astrocyte - cerebellum, donor3	11661-122F5	95.23	3.99	3.57	1.89	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	61.00	3.14	2.09	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	71.67	1.46	0.97	0.81	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	59.51	1.34	1.04	0.60	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	162.85	4.24	1.72	2.87	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	169.13	5.01	1.88	2.38	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	162.50	4.10	1.82	1.25	1.37
Basophils, donor1	12241-129G9	22.75	1.83	1.57	0.00	0.52
Basophils, donor2	12242-129H1	27.78	1.08	2.89	0.36	0.00
Basophils, donor3	12243-129H2	33.52	1.62	1.47	0.59	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	53.47	1.51	0.65	0.86	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	119.33	0.91	0.46	1.37	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	132.43	1.26	0.63	1.26	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	101.90	0.83	0.62	1.87	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	58.26	1.38	1.38	1.15	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	49.13	1.44	0.72	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	96.87	3.09	4.02	1.44	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	106.44	1.40	2.56	2.79	1.86
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	59.80	6.08	2.88	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	27.61	2.82	0.56	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	31.92	0.74	0.19	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	30.30	0.44	0.44	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	52.08	2.55	1.98	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	54.21	1.52	1.90	1.14	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	57.53	4.93	1.64	1.31	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	33.39	1.88	1.59	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	34.40	1.51	1.81	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	33.88	0.47	0.47	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	19.75	1.51	0.67	0.17	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	14.63	0.83	0.83	0.28	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	16.61	0.74	0.99	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	21.34	2.55	0.59	0.20	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	28.31	1.60	0.89	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	20.24	1.09	1.09	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.33	1.40	0.23	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	30.10	1.58	2.11	0.00	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	18.86	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	24.25	2.23	0.89	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	30.93	1.00	1.00	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	16.45	0.62	1.25	0.62	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	20.13	1.14	0.23	0.23	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.45	1.36	0.90	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	20.51	1.31	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	30.40	1.61	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	30.71	2.09	1.22	0.17	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	30.30	0.42	1.26	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.94	1.10	0.37	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	19.37	2.47	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	11.41	0.00	0.44	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	19.01	1.39	1.05	0.17	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	21.93	1.49	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	20.26	0.65	1.94	0.00	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.43	0.82	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.29	1.39	1.16	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.37	0.93	0.23	0.00	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	58.63	0.87	0.22	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	50.82	1.85	1.15	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	55.89	1.08	0.65	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	59.80	2.02	0.62	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	48.20	1.75	0.87	0.35	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	43.70	1.34	0.67	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	60.48	2.04	0.77	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	55.77	1.10	0.88	0.88	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	62.32	0.21	1.05	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	27.80	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	30.03	2.07	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	54.37	1.60	1.07	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	56.29	2.14	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	41.41	1.40	2.11	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	54.12	2.35	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	52.73	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	35.34	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	26.12	0.73	2.90	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	36.85	2.52	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	118.39	3.64	3.64	0.40	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	89.89	2.40	3.60	0.40	1.60
CD34+ Progenitors, donor1	11545-120B6	39.16	7.03	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	24.72	1.69	0.56	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	95.07	5.26	3.76	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	80.27	5.19	4.06	0.90	0.68
CD4+ T Cells, donor1	11225-116C1	25.71	1.07	1.79	0.00	3.93
CD4+ T Cells, donor2	11306-117C1	44.70	1.84	1.22	0.00	2.45
CD4+ T Cells, donor3	11382-118B5	38.12	0.91	0.61	0.00	4.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	49.77	3.57	1.28	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	56.82	1.12	1.57	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	54.90	3.74	2.30	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	41.72	1.90	0.47	0.00	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	58.29	0.70	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	82.41	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	59.68	3.61	1.88	0.14	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	73.72	3.39	1.86	0.34	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	68.51	1.61	1.29	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	36.31	0.90	1.34	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	38.43	1.05	0.00	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	38.72	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	66.62	1.69	2.53	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	76.87	2.49	1.45	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	82.86	3.34	1.00	0.33	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	48.13	1.90	1.63	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	57.88	1.07	2.14	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	62.76	0.00	1.79	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	60.26	3.15	2.23	0.19	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	57.62	2.17	2.38	0.22	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	50.44	1.47	1.26	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	40.45	2.53	1.01	0.00	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	50.26	1.30	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	37.92	3.05	0.87	0.00	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	47.51	1.98	1.48	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	47.08	1.85	2.77	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	57.23	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	70.06	2.22	1.66	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	72.14	1.72	3.44	2.21	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	70.84	0.00	1.54	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	57.30	1.07	0.72	0.72	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	54.01	4.15	4.15	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	33.07	0.65	1.31	0.33	3.27
CD8+ T Cells, donor2	11307-117C2	28.91	1.50	0.00	0.00	3.00
CD8+ T Cells, donor3	11383-118B6	46.21	1.77	0.50	0.00	3.53
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	58.04	3.21	2.52	3.90	2.75
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	46.01	2.16	1.68	0.72	1.92
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	48.97	3.01	2.19	2.19	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	76.55	3.00	2.40	1.50	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	55.92	3.60	2.16	0.96	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	57.30	2.50	1.82	2.73	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	61.49	1.74	1.74	2.17	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	56.06	2.37	1.84	2.11	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	55.35	1.41	0.23	1.88	1.88
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	61.88	2.72	1.81	3.62	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	69.72	1.74	0.29	3.20	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	58.88	1.60	0.53	4.00	3.46
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	32.83	2.19	2.63	1.31	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	32.79	1.82	0.91	1.82	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	33.56	0.75	2.98	4.48	4.48
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	46.10	2.16	0.72	1.08	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	56.97	2.59	0.58	3.45	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	55.39	2.83	2.12	2.12	1.89
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	67.50	2.85	2.54	1.58	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	55.98	1.54	0.92	2.77	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	59.95	1.60	1.60	3.53	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	65.78	1.91	1.15	2.68	1.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	49.26	3.15	1.58	2.36	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	48.41	5.29	0.76	2.27	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	41.75	2.41	4.01	3.21	6.42
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	49.66	0.70	3.50	1.40	4.90
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	53.09	8.01	3.01	3.01	2.00
Cardiac Myocyte, donor1	11525-119I4	63.97	0.00	0.00	3.66	1.83
Cardiac Myocyte, donor2	11605-120I3	71.15	1.48	1.98	1.98	0.00
Cardiac Myocyte, donor3	11686-122I3	42.41	1.79	1.16	0.42	0.11
Chondrocyte - de diff, donor1	11261-116G1	64.83	3.47	4.51	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	48.33	2.49	1.78	2.49	0.00
Chondrocyte - de diff, donor3	11410-118E6	64.17	3.07	2.50	0.91	0.23
Chondrocyte - re diff, donor2	11339-117F7	24.17	3.58	0.90	1.79	0.90
Chondrocyte - re diff, donor3	11411-118E7	47.72	3.24	3.64	1.21	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	56.23	1.95	3.33	0.69	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	54.72	2.35	0.86	0.86	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	56.90	1.15	1.24	0.44	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	76.39	5.14	1.83	2.02	0.46
Corneal Epithelial Cells, donor1	11526-119I5	59.28	0.88	0.44	0.44	1.10
Corneal Epithelial Cells, donor2	11606-120I4	103.52	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	91.00	0.77	1.02	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	51.84	3.63	4.79	1.65	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	47.31	1.58	4.73	2.21	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	20.70	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	61.99	2.70	1.19	1.84	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	41.68	4.44	4.10	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	42.44	4.57	5.88	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	30.97	5.32	2.90	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	44.86	1.33	0.83	0.33	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	69.24	0.59	2.93	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	41.57	0.57	0.85	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	66.45	0.39	0.39	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	66.03	1.16	2.04	0.58	0.87
Endothelial Cells - Artery, donor2	11341-117F9	77.88	0.71	1.41	1.88	2.12
Endothelial Cells - Artery, donor3	11413-118E9	72.75	1.05	1.40	0.53	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	28.15	1.99	1.99	0.00	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	33.47	1.22	0.61	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	25.09	1.13	2.54	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	43.68	1.49	1.19	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	58.31	2.08	0.52	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	43.24	0.57	1.42	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	57.62	3.60	0.80	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	57.65	0.52	0.52	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	48.08	1.49	0.99	0.12	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	74.52	0.22	0.43	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	65.09	0.61	0.73	0.37	0.24
Endothelial Cells - Vein, donor1	11267-116G7	72.80	1.14	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	43.31	2.79	1.40	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	63.12	2.83	0.31	0.63	0.79
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	37.96	6.60	0.00	0.00	3.30
Eosinophils, donor3	12246-129H5	14.27	10.70	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	62.06	2.44	1.47	1.22	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	43.68	0.00	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	50.08	3.28	3.69	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	45.33	2.41	0.88	0.55	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	77.89	4.77	4.01	2.06	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	44.75	3.27	1.33	0.97	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	27.43	1.50	0.68	0.14	5.60
Fibroblast - Aortic Adventitial, donor2	11326-117E3	51.57	2.11	1.79	0.74	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	34.25	3.95	0.79	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	75.41	2.66	1.33	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	64.42	2.27	0.91	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	34.11	3.03	3.03	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	49.37	1.26	1.10	0.32	0.32
Fibroblast - Cardiac, donor4	11452-119A3	44.56	5.15	1.21	0.91	0.91
Fibroblast - Cardiac, donor5	11456-119A7	51.40	1.27	1.78	0.51	0.38
Fibroblast - Cardiac, donor6	11460-119B2	64.88	2.12	0.76	0.91	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	62.44	3.48	4.96	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	62.13	3.02	2.16	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	46.87	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	86.72	2.54	3.92	2.54	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	69.88	5.09	4.41	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	74.19	0.94	0.47	0.00	0.47
Fibroblast - Dermal, donor2	11346-117G5	65.56	2.36	0.47	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	67.45	1.45	1.21	0.48	0.36
Fibroblast - Dermal, donor4	11450-119A1	74.95	0.90	0.90	0.90	0.11
Fibroblast - Dermal, donor5	11454-119A5	82.69	0.70	1.22	2.09	0.17
Fibroblast - Dermal, donor6	11458-119A9	104.93	0.97	0.65	2.44	0.16
Fibroblast - Gingival, donor1	11237-116D4	43.94	2.08	0.62	1.46	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	67.07	3.93	2.36	1.83	0.52
Fibroblast - Gingival, donor2	11318-117D4	69.58	0.79	0.79	0.53	0.40
Fibroblast - Gingival, donor3	11394-118C8	59.17	1.64	1.45	1.16	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	2.08	1.04	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	39.65	0.88	1.94	0.35	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	76.86	1.56	0.62	2.18	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	70.18	2.98	0.95	2.84	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	36.70	0.35	1.41	2.47	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	77.95	1.90	1.32	2.78	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	69.13	1.91	0.82	1.91	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	79.86	1.86	1.32	2.63	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	71.32	4.55	5.43	1.03	0.29
Fibroblast - Lung, donor1	11270-116H1	59.81	0.00	0.00	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	56.70	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	92.22	2.11	1.06	1.48	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	94.13	0.83	3.33	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	88.11	1.40	1.40	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	91.24	1.96	0.84	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	72.67	2.44	1.62	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	187.73	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	77.43	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	57.42	2.72	0.58	1.16	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	83.12	0.61	0.46	0.61	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	39.47	1.22	1.22	0.61	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	96.17	2.29	1.14	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	61.02	1.62	1.08	1.08	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	34.21	0.93	2.20	0.35	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	45.98	1.11	1.33	0.22	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	64.61	0.81	2.24	2.44	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	94.22	2.00	1.34	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	81.84	1.98	1.58	3.16	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	36.32	1.79	1.19	0.60	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	35.70	2.49	3.02	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	43.56	2.76	3.35	0.39	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	42.12	1.81	0.60	0.00	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	51.38	3.89	3.13	0.22	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	45.55	1.77	1.01	1.01	1.52
Fibroblast - skin normal, donor1	11553-120C5	54.31	2.79	2.13	0.49	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	28.67	2.01	0.60	0.00	2.01
Fibroblast - skin normal, donor2	11561-120D4	50.63	2.21	2.71	0.70	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	46.24	1.81	0.91	0.60	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	39.35	4.23	4.14	0.33	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	68.04	12.31	8.55	0.00	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	39.41	1.97	0.33	0.33	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	53.79	1.81	1.92	0.32	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	58.70	1.52	1.18	0.67	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	59.12	4.08	2.67	0.47	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	61.88	2.61	2.61	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	29.12	0.69	0.35	0.35	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	38.26	1.82	0.52	0.52	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	31.17	0.77	0.26	1.28	1.79
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	47.46	0.77	5.36	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	61.25	0.00	1.28	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	113.25	3.14	1.43	2.85	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	99.82	5.24	2.76	1.93	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	88.36	7.08	4.57	2.51	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	101.84	3.76	1.39	2.58	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	112.34	2.91	3.97	2.38	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	117.41	6.52	3.26	3.59	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	95.08	1.33	2.21	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	59.36	1.13	1.98	2.97	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	64.53	2.59	2.59	1.97	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	56.41	2.95	1.88	1.61	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	46.71	1.61	1.73	1.73	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	44.43	2.35	1.80	1.11	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	48.18	3.86	2.24	1.42	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	53.62	4.34	2.97	0.91	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	39.49	1.12	2.37	0.62	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	51.15	1.31	1.75	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	71.51	2.66	2.66	2.36	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	51.03	1.91	3.18	1.75	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	65.46	2.01	1.56	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	68.76	3.63	3.23	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	59.54	3.73	3.56	1.19	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	43.80	2.93	3.19	0.71	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	62.12	8.43	5.51	0.73	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	60.80	7.00	7.00	1.02	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	65.95	2.99	3.65	1.55	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.43	4.91	4.08	0.42	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	47.98	3.88	3.27	1.43	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	76.33	5.57	5.16	0.41	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	58.34	4.96	4.38	1.84	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	65.71	2.50	3.34	1.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	68.55	3.53	5.29	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	74.90	5.78	5.53	0.74	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	64.19	3.89	2.92	1.62	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	80.82	8.02	7.70	0.96	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	58.94	3.03	3.22	1.23	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	65.01	3.64	2.69	1.27	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	65.68	7.60	6.69	1.52	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	55.09	3.24	2.40	1.46	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	70.48	6.81	4.17	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	69.30	6.17	5.61	1.96	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	52.13	2.78	2.78	1.48	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	76.48	3.21	3.74	1.60	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	49.27	2.75	1.53	1.22	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	56.35	2.46	2.85	1.04	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	84.57	4.34	2.17	2.44	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	55.86	3.50	4.42	0.92	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	52.20	2.41	3.07	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	93.22	5.95	5.95	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	50.26	2.37	2.37	1.06	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	47.21	1.21	1.61	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	51.85	11.18	8.90	1.27	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	54.14	1.59	0.80	2.39	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	58.09	1.85	2.16	1.69	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	69.76	2.86	3.89	2.25	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	48.19	4.69	3.76	0.94	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	53.40	3.96	1.41	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	45.66	3.23	1.38	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	0.00	0.00	9.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	66.14	4.25	1.16	1.93	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	73.81	1.60	3.21	8.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	69.55	1.74	6.96	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	60.86	0.65	0.33	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	57.65	2.47	4.94	1.65	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	73.31	3.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	64.60	2.80	1.68	1.68	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	55.24	3.60	3.60	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	68.78	2.52	4.19	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	70.93	3.50	1.27	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	64.54	2.72	2.38	2.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	81.44	2.09	4.18	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	79.03	4.01	7.45	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	68.96	4.14	4.14	0.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	59.30	1.69	3.39	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	86.57	1.24	3.73	2.07	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	73.64	4.83	3.22	2.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	89.56	5.27	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	59.58	5.00	4.61	1.54	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	54.44	4.56	1.63	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	84.94	9.36	3.34	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	73.59	2.70	2.31	1.54	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	59.57	6.50	1.71	1.03	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	74.54	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	75.50	4.25	4.25	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	62.16	1.81	3.02	3.62	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	80.88	4.07	6.10	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	71.39	6.38	4.39	1.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	76.96	6.91	3.95	1.48	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	61.38	4.72	3.54	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	69.43	5.83	5.83	2.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	72.42	4.39	3.95	1.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	48.32	6.78	4.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	66.26	4.18	2.98	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	70.85	4.37	3.40	3.40	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	67.34	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	63.20	3.33	1.66	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	73.09	1.12	1.12	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	60.26	1.90	1.59	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	66.84	3.76	2.92	0.42	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	59.18	2.79	1.62	4.41	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	67.35	3.21	1.52	3.04	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	59.83	1.82	2.05	4.10	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	58.70	3.17	1.53	3.50	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	67.27	4.73	1.72	2.36	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	53.82	0.86	1.29	2.80	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	60.53	2.86	1.49	3.86	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	61.41	2.74	1.89	2.74	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	57.99	1.92	1.28	2.24	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	67.15	0.56	0.00	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	67.52	1.73	1.30	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	61.73	1.76	1.41	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	83.55	2.18	2.91	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	51.75	1.40	0.52	1.05	0.52
Hepatocyte, donor1	11523-119I2	121.06	0.00	0.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	72.18	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	89.58	1.23	2.45	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	105.08	1.96	1.96	0.00	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	55.06	1.75	1.05	1.57	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	48.71	1.37	0.96	0.55	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	79.60	9.55	6.37	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	0.00	6.68	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	58.14	0.00	2.77	0.00	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	60.06	0.00	5.01	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	106.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	71.76	2.56	0.00	5.13	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	82.27	4.57	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	64.97	1.62	1.62	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	98.37	3.33	6.67	6.67	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	105.29	3.63	7.26	0.00	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	84.70	6.62	3.97	2.65	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	85.37	4.43	2.22	3.33	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	83.81	0.00	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	62.99	5.04	6.30	3.15	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	55.68	1.55	4.64	4.64	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	146.35	0.00	0.00	14.63	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	58.79	5.17	4.52	3.88	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	78.89	0.00	4.83	3.22	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	72.52	3.26	3.26	4.89	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	64.23	2.52	2.94	1.68	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	58.67	6.43	2.41	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	85.87	4.62	4.62	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	70.33	1.89	4.72	1.89	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	93.42	4.53	1.81	2.72	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	65.64	5.38	2.15	3.23	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	74.96	6.35	2.54	1.27	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	79.71	3.19	3.19	4.46	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	80.20	5.47	0.00	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	65.69	4.28	2.86	1.43	4.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	53.09	0.00	9.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	70.37	1.85	2.16	4.63	1.85
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	75.51	5.27	3.51	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	113.15	3.14	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	68.84	3.48	6.95	2.78	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	110.65	4.43	4.43	2.21	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	123.20	0.00	3.24	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	77.60	6.10	6.10	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	119.24	0.00	4.50	11.25	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	132.41	10.45	6.97	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	86.41	4.27	9.60	2.13	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	90.05	1.39	2.77	4.16	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	94.04	2.85	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	68.11	3.68	3.68	10.12	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	127.06	9.08	30.25	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	31.04	18.63	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	95.16	7.40	6.34	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	29.70	3.10	1.22	0.00	0.16
Keratinocyte - epidermal, donor2	11349-117G8	38.65	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	51.02	0.85	0.66	1.23	0.00
Keratinocyte - oral, donor1	11251-116E9	62.66	2.84	1.25	1.25	0.11
Keratocytes, donor1	11527-119I6	68.42	3.78	5.16	0.00	0.00
Keratocytes, donor2	11607-120I5	121.87	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	50.58	4.54	5.14	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	129.68	8.79	0.00	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	48.54	1.08	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	57.44	3.69	2.08	1.50	0.46
Lens Epithelial Cells, donor3	11690-122I7	27.04	2.42	2.12	0.10	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	50.87	1.30	1.66	0.71	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	43.26	1.12	1.40	1.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	50.06	0.63	2.99	0.94	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	49.47	2.15	2.15	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	45.38	1.26	1.26	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	53.26	1.29	1.51	0.86	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	36.11	1.23	1.64	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	51.07	0.76	0.25	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	48.70	1.55	1.97	0.70	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	35.60	1.19	0.79	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	48.86	0.78	1.16	0.78	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	50.18	1.48	1.67	0.93	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	40.07	0.35	2.09	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	46.04	1.43	1.19	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	48.76	0.82	1.10	0.69	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	40.34	0.92	0.92	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	43.96	0.94	1.25	0.94	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	54.90	1.46	1.83	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	39.82	1.65	0.66	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	51.25	0.88	0.88	1.46	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	60.49	2.24	1.49	1.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	32.49	0.97	0.48	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	48.20	1.08	2.15	0.81	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	51.47	1.36	1.36	1.82	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	38.88	1.56	1.56	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	47.53	0.84	0.63	1.47	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	53.83	1.20	1.20	1.20	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	47.46	1.38	1.38	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	48.54	1.32	1.51	0.75	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	46.65	1.38	2.12	0.95	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	38.77	0.48	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	44.66	0.99	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	50.30	0.87	1.49	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	41.09	0.74	2.22	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	39.78	1.24	0.99	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	51.84	0.96	2.06	0.82	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	40.53	0.96	1.93	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	40.17	1.22	0.61	0.30	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	45.91	1.96	1.12	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	38.76	0.71	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	52.84	0.97	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	56.33	1.40	2.49	0.93	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	38.68	1.43	1.07	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	53.90	1.63	0.65	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	55.09	3.06	1.65	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	46.41	1.73	2.10	0.12	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	51.48	1.79	2.82	0.77	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	55.79	0.60	1.19	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	33.99	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	66.74	2.30	2.30	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	62.35	2.23	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	47.81	3.39	0.00	1.27	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	54.86	2.81	0.70	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	54.17	1.87	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	40.19	4.64	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	61.85	3.57	1.19	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	36.87	2.49	2.49	1.13	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	49.73	1.74	1.16	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	52.22	4.95	1.35	2.25	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	47.96	2.71	2.03	1.49	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	49.30	2.05	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	53.28	2.12	0.35	1.06	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	57.30	2.67	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	50.94	3.06	2.55	1.53	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	56.56	1.33	0.53	1.07	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	59.71	1.51	1.32	1.32	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	63.20	1.23	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	40.77	0.00	0.82	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	49.56	2.08	1.25	0.83	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	51.29	3.36	0.84	0.56	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	69.03	2.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	57.77	1.16	2.03	1.45	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	45.14	0.90	1.20	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	49.79	3.32	1.11	2.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	55.85	3.89	0.71	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	60.48	2.21	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	58.72	0.00	2.30	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	57.18	2.69	0.77	1.15	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	49.25	3.96	0.57	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	60.71	1.64	0.82	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	61.91	1.36	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	62.48	2.15	0.72	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	56.02	2.24	0.75	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	58.34	1.49	1.86	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	48.24	2.15	2.15	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	58.23	2.57	1.71	1.71	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	57.31	4.66	0.67	1.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	54.30	1.21	0.60	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	50.48	2.13	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	58.43	2.75	1.37	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	53.14	2.68	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	56.56	2.69	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	48.52	2.96	0.37	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	31.40	2.33	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	49.71	1.06	0.00	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	41.22	2.00	1.60	1.20	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	54.52	4.36	0.73	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	58.26	1.53	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	58.70	2.96	0.49	1.48	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	38.58	1.88	0.94	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	59.84	2.01	1.51	0.50	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	60.38	2.25	0.90	0.90	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	49.91	3.44	3.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	66.80	2.23	1.78	0.45	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	51.62	2.35	0.39	1.17	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	48.82	1.98	0.66	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	43.07	1.04	0.52	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.88	2.19	0.88	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	46.41	1.68	1.12	1.68	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	56.97	2.21	0.88	1.77	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	47.44	2.31	1.54	2.70	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	54.69	0.00	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	51.91	2.40	1.92	1.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	56.05	3.18	1.99	1.59	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	47.39	1.82	1.82	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	49.11	2.77	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	46.36	2.28	1.52	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	55.26	2.07	1.55	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	48.37	1.21	0.00	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	46.27	2.54	1.27	1.90	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	47.98	2.13	1.07	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	43.10	1.72	0.57	0.57	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	58.11	3.60	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	55.88	4.24	2.12	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	55.61	1.70	1.13	0.57	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	48.26	1.25	0.00	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	62.64	3.13	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	53.45	2.09	1.25	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	56.69	2.32	1.39	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	60.21	0.67	0.67	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	55.60	3.21	2.67	1.07	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	56.17	2.42	2.42	0.81	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	59.65	0.92	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	65.79	0.00	0.00	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	57.56	1.14	1.71	1.14	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	46.78	0.00	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	61.28	2.19	1.09	1.64	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	61.92	2.23	0.89	1.78	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	41.07	1.82	2.08	0.52	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	67.64	3.98	0.66	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	62.36	0.00	0.00	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	41.71	2.96	0.91	0.91	0.00
Macrophage - monocyte derived, donor2	11313-117C8	60.37	2.20	1.47	1.47	0.00
Macrophage - monocyte derived, donor3	11389-118C3	69.74	1.05	0.52	3.41	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	29.21	1.06	1.06	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	37.55	1.11	1.27	0.63	0.95
Mallassez-derived cells, donor3	11930-125I4	46.28	0.83	0.69	0.56	0.97
Mammary Epithelial Cell, donor1	11273-116H4	45.14	4.19	1.49	1.20	0.20
Mammary Epithelial Cell, donor2	11350-117G9	49.80	0.87	1.45	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	51.13	0.75	0.75	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	20.34	5.42	3.39	0.00	0.00
Mast cell, donor1	11563-120D6	50.50	4.22	3.57	0.32	0.65
Mast cell, donor2	11565-120D8	28.53	1.49	0.59	0.59	1.19
Mast cell, donor3	11566-120D9	37.37	4.73	1.35	0.00	0.90
Mast cell, donor4	11567-120E1	32.98	3.01	1.06	0.53	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	57.00	3.88	1.89	0.55	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	39.11	4.09	4.09	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	58.97	4.93	1.38	0.23	0.23
Mast cell, expanded, donor8	11941-126A6	48.03	2.85	2.01	1.00	0.00
Melanocyte - dark, donor1	11502-119F8	60.10	0.90	1.49	0.40	0.70
Melanocyte - dark, donor2	11582-120F7	60.91	0.69	1.04	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	73.89	1.52	0.87	1.01	0.36
Melanocyte - light, donor1	11274-116H5	42.08	0.94	0.94	0.00	0.00
Melanocyte - light, donor2	11351-117H1	60.06	1.36	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	57.24	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	69.35	0.94	0.83	0.62	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	61.86	1.88	1.88	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	60.80	4.55	2.41	0.54	0.80
Meningeal Cells, donor1	11493-119E8	77.91	1.49	1.74	0.74	0.62
Meningeal Cells, donor2	11573-120E7	96.83	0.88	0.88	1.32	0.00
Meningeal Cells, donor3	11654-122E7	52.16	1.71	0.73	0.65	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	59.88	1.43	1.14	1.43	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	24.96	2.92	1.51	0.40	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	144.56	2.63	7.88	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	128.20	1.31	1.31	3.92	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	81.81	0.72	0.00	2.87	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.92	1.06	0.85	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	55.29	1.01	0.50	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	100.65	1.10	1.54	0.66	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	100.82	0.73	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	106.60	0.61	1.43	0.41	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	64.13	4.57	3.46	0.00	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	70.63	2.60	1.49	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	35.39	3.55	2.63	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	75.08	6.23	5.64	1.19	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	67.73	11.68	2.34	4.67	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	108.87	2.56	2.56	6.40	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	46.43	0.35	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	29.08	1.88	1.25	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	75.47	0.73	0.73	2.18	0.73
Mesothelial Cells, donor1	11247-116E5	36.86	2.65	1.59	0.27	1.06
Mesothelial Cells, donor2	12156-128G5	30.03	2.00	1.00	1.00	0.50
Mesothelial Cells, donor3	11402-118D7	35.27	1.01	0.36	0.14	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	2.70	4.05	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	58.37	1.48	1.72	1.48	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	78.33	2.94	0.59	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	0.00	0.00	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	52.07	3.10	0.93	1.55	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	53.10	0.62	0.83	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	0.00	0.00	6.95	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	56.31	2.25	2.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	63.77	0.93	0.93	0.93	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	50.60	2.24	0.61	1.63	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	53.85	0.40	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	46.90	1.77	0.88	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	64.59	1.52	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	27.63	0.00	0.00	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	41.81	0.85	1.27	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	43.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	32.79	2.98	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	57.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	43.16	0.75	0.75	1.51	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	38.74	0.48	0.95	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	33.73	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	44.67	2.76	1.61	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	50.06	1.26	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	45.45	0.82	0.41	2.04	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	43.12	2.79	0.00	0.43	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	38.23	0.89	0.67	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	30.66	1.53	0.88	0.88	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	40.56	1.01	1.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00	0.00	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	24.73	1.63	0.82	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	34.70	0.88	1.18	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	28.35	2.40	1.92	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	53.23	1.60	0.80	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	34.28	0.00	1.37	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	27.53	1.00	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	0.00	0.00	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	24.96	0.44	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	48.56	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	38.42	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	34.46	1.49	1.24	1.49	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	34.79	0.70	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	41.99	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	38.63	3.42	0.68	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	38.95	0.44	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	27.34	0.36	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	34.51	1.96	0.00	1.12	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	55.28	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	37.88	0.00	1.17	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	23.83	0.60	0.60	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	58.43	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	25.86	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	48.94	2.28	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	35.65	0.83	0.83	1.38	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	28.51	1.30	0.52	1.04	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	64.78	1.29	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	38.75	0.00	0.00	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	22.42	0.53	0.00	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	61.06	1.20	0.60	0.90	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	28.53	1.13	0.57	0.99	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	38.86	2.23	1.59	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	62.80	2.65	1.33	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	46.26	0.38	0.38	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	33.24	1.70	1.14	0.28	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	70.05	0.98	0.49	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	43.01	1.30	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	26.46	0.88	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	69.77	2.59	0.86	1.15	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.08	2.47	1.24	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	33.65	2.08	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	79.10	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	67.73	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	83.79	1.31	1.31	2.63	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	76.79	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	39.14	1.19	2.17	0.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	59.60	0.93	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	99.52	2.25	1.88	2.63	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	62.86	0.53	0.80	1.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	37.66	1.13	0.90	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	66.31	2.95	0.74	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	67.79	1.83	2.20	1.83	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	57.56	3.11	0.00	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	39.01	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	69.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	76.76	6.06	3.03	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	78.42	2.11	0.42	1.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	28.60	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	18.44	0.00	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.96	0.81	0.81	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	49.84	1.51	3.02	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	0.00	0.00	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	43.52	2.37	2.15	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	65.85	2.09	1.57	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	112.14	5.34	1.33	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	76.80	2.92	0.00	0.83	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	146.60	6.46	3.23	3.80	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	124.48	0.00	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	53.04	3.40	2.72	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	5.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	68.22	2.09	0.42	2.51	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	119.94	5.11	1.16	2.32	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	114.04	4.05	2.43	1.08	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	75.69	1.47	1.05	0.21	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	88.85	4.47	1.49	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	58.74	4.87	3.79	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	93.17	5.21	2.27	2.04	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	76.75	2.78	1.14	1.47	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	52.85	2.92	2.37	0.73	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	64.71	6.90	1.59	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	58.83	3.00	3.00	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	76.14	13.13	9.19	0.98	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	83.59	4.23	3.42	0.81	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	50.80	3.00	1.23	1.06	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	39.38	2.81	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	62.06	2.76	3.68	1.38	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	96.72	4.82	2.89	0.96	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	87.95	9.31	6.21	1.72	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	5.06	7.59	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.67	2.01	0.45	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	39.38	4.66	1.69	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	57.68	6.17	2.61	0.71	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	81.99	4.29	1.29	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	116.96	4.00	2.67	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	25.25	2.71	1.35	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	47.62	3.17	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	95.65	5.57	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	69.24	6.81	4.16	0.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	76.26	3.58	1.96	0.98	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	112.87	4.79	5.23	1.74	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	35.28	2.26	0.45	1.36	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	58.21	5.29	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	68.48	5.32	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	106.15	4.46	2.98	1.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	70.06	2.68	2.68	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	65.93	4.54	3.33	0.91	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	37.57	1.33	1.33	0.88	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	52.86	3.39	2.71	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	10.22	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	78.65	7.93	2.44	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	55.08	4.09	2.83	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	156.77	5.15	3.63	1.82	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	53.01	4.75	4.75	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	44.21	5.67	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	35.03	1.61	0.37	0.99	0.50
Myoblast, donor2	11322-117D8	64.44	0.77	1.53	0.96	1.15
Myoblast, donor3	11398-118D3	41.70	2.19	1.01	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	103.17	1.90	2.33	1.17	0.15
Natural Killer Cells, donor1	11230-116C6	33.52	1.23	1.23	0.62	2.46
Natural Killer Cells, donor2	11311-117C6	34.08	1.51	0.00	0.30	1.81
Natural Killer Cells, donor3	11387-118C1	37.92	1.29	0.18	0.37	1.66
Neural stem cells, donor1	11275-116H6	52.26	8.35	4.36	1.09	1.09
Neural stem cells, donor2	11352-117H2	55.84	11.55	1.93	0.00	0.00
Neurons, donor1	11494-119E9	100.14	4.55	1.14	1.14	0.00
Neurons, donor2	11574-120E8	63.85	3.96	1.76	1.10	0.22
Neurons, donor3	11655-122E8	123.32	3.29	4.93	4.93	0.00
Neutrophils, donor1	11233-116C9	8.35	0.93	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	20.29	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	12.83	2.44	1.83	0.61	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	64.24	6.41	5.34	0.47	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	79.12	5.54	3.91	1.63	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	70.19	2.21	1.20	2.61	0.00
Olfactory epithelial cells, donor1	11933-125I7	49.97	3.17	4.27	0.28	0.41
Olfactory epithelial cells, donor2	11934-125I8	75.27	4.34	3.04	2.03	0.72
Olfactory epithelial cells, donor3	11935-125I9	55.50	2.61	1.82	0.57	0.68
Olfactory epithelial cells, donor4	11936-126A1	54.54	3.12	2.34	1.46	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	55.97	1.81	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	56.15	5.10	4.89	1.28	0.00
Osteoblast - differentiated, donor2	11353-117H3	83.45	3.43	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	76.35	6.21	3.10	0.62	0.00
Osteoblast, donor1	11277-116H8	75.05	3.52	2.35	2.35	0.59
Osteoblast, donor2	11354-117H4	49.86	3.51	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	77.13	0.18	1.07	0.89	0.18
Pancreatic stromal cells, donor1	11249-116E7	49.78	2.36	1.10	0.51	0.17
Pericytes, donor1	11491-119E6	97.80	4.90	5.67	1.22	0.11
Pericytes, donor2	11571-120E5	123.37	4.30	3.85	1.36	0.23
Pericytes, donor3	11652-122E5	75.68	1.02	2.24	0.61	0.20
Perineurial Cells, donor1	11499-119F5	45.10	1.81	1.58	0.79	0.11
Perineurial Cells, donor2	11579-120F4	55.02	1.47	1.38	0.64	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	36.34	0.96	0.00	0.00	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	38.20	0.49	0.49	0.00	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	42.06	0.65	1.04	0.13	1.16
Placental Epithelial Cells, donor1	11278-116H9	70.31	1.20	0.00	1.67	0.00
Placental Epithelial Cells, donor2	11355-117H5	66.53	3.33	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	72.44	3.14	1.77	0.39	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	41.77	1.58	0.63	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	30.20	2.81	3.94	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	21.93	1.70	0.65	0.39	2.09
Preadipocyte - breast, donor2	11328-117E5	43.90	2.03	2.03	1.35	0.00
Preadipocyte - omental, donor1	11468-119C1	26.21	4.80	3.41	0.21	0.32
Preadipocyte - omental, donor2	11329-117E6	36.23	2.62	1.31	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	41.40	2.86	1.43	0.86	0.57
Preadipocyte - perirenal, donor1	11469-119C2	60.04	1.97	2.95	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	57.43	2.46	1.84	0.31	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	83.40	1.42	0.89	0.00	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	74.75	1.87	1.19	1.19	0.68
Preadipocyte - visceral, donor1	11280-116I2	58.40	2.24	1.86	0.84	0.65
Preadipocyte - visceral, donor2	11357-117H7	62.12	3.68	1.84	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	86.52	1.99	0.94	0.73	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	45.10	1.36	1.21	0.60	0.45
Prostate Epithelial Cells, donor2	11331-117E8	33.72	0.68	0.68	0.41	0.95
Prostate Epithelial Cells, donor3	11404-118D9	27.99	0.37	0.73	0.31	0.18
Prostate Stromal Cells, donor1	11254-116F3	46.81	1.03	1.14	0.57	0.46
Prostate Stromal Cells, donor2	11332-117E9	67.24	1.61	1.26	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	65.69	1.98	1.67	0.31	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	57.30	1.09	1.46	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	38.40	1.46	1.32	0.97	0.35
Renal Epithelial Cells, donor1	11517-119H5	103.98	1.01	0.51	1.52	1.01
Renal Epithelial Cells, donor2	11597-120H4	77.53	0.00	2.85	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	37.79	2.43	0.64	0.64	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	78.98	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	86.38	0.67	1.62	0.27	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	59.94	0.44	0.44	0.22	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	79.19	1.33	1.33	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	75.27	1.32	1.32	0.88	0.44
Renal Mesangial Cells, donor2	11598-120H5	79.63	0.00	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	100.98	1.66	1.39	2.50	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	73.82	0.27	0.27	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	74.22	0.00	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	76.95	0.77	0.19	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	63.01	0.78	0.52	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	48.61	2.56	1.42	0.00	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	79.24	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	38.39	1.76	5.27	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	67.62	1.60	0.53	1.47	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	28.59	1.79	3.57	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	44.58	6.05	4.40	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	40.02	4.64	4.64	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	38.10	1.69	2.86	1.56	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	50.65	1.49	0.99	2.38	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	45.51	1.78	1.34	1.23	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	47.26	2.73	2.11	0.74	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	53.73	1.05	1.05	1.05	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	51.31	2.31	1.85	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	54.63	2.33	0.55	2.19	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	50.37	1.51	1.21	0.30	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	32.79	1.79	1.08	0.36	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	58.39	1.15	1.15	1.86	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	54.62	2.25	1.93	1.40	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	65.72	1.77	1.55	1.33	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	65.38	1.91	0.96	1.15	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	48.91	1.40	1.02	1.30	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	42.28	2.07	2.07	0.94	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	63.70	0.93	1.06	1.73	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	53.25	1.36	1.36	0.78	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	50.41	2.29	1.53	0.76	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	55.85	1.71	0.96	1.50	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	56.34	1.96	1.96	0.56	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	55.20	2.73	1.71	1.37	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	64.00	1.28	1.09	1.46	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	49.42	2.08	1.10	2.08	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	53.33	1.34	0.94	1.61	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	67.70	2.83	1.42	1.89	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	49.40	1.39	1.79	1.79	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	62.90	1.40	2.34	1.64	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	67.18	2.49	1.04	1.66	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	52.87	1.99	1.99	0.88	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	56.61	1.46	0.84	0.84	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	69.31	1.35	1.62	1.48	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	62.50	1.19	1.70	1.87	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	62.47	0.96	0.77	0.77	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	71.01	2.06	1.20	2.06	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	47.32	0.55	0.96	2.06	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	55.49	1.31	1.81	1.48	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	65.27	1.53	0.85	2.22	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	61.70	0.89	1.63	1.92	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	61.57	2.13	1.33	1.07	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	52.26	2.07	3.18	1.11	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	51.91	2.38	0.95	1.67	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	62.28	4.23	2.02	1.01	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	53.11	2.26	2.83	1.22	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	54.50	2.79	2.45	1.40	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	48.05	1.81	2.12	1.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	55.07	3.55	2.69	2.08	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	34.20	7.13	4.95	1.31	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	43.81	3.04	4.87	0.61	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	57.87	3.32	3.01	2.71	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	34.83	1.58	1.81	1.36	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	45.23	3.29	4.19	2.40	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	35.78	5.43	4.72	0.83	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	39.06	1.92	3.20	0.85	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	53.49	2.40	4.81	1.20	1.20
Schwann Cells, donor1	11498-119F4	124.69	0.94	1.50	0.75	0.19
Schwann Cells, donor2	11578-120F3	47.63	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	63.53	1.53	0.44	1.53	0.22
Sebocyte, donor1	11220-116B5	44.92	0.55	3.29	0.55	0.55
Sebocyte, donor2	11301-117B5	72.61	1.84	0.92	0.46	0.92
Sebocyte, donor3	11378-118B1	82.03	1.03	1.44	1.03	0.82
Sertoli Cells, donor1	11255-116F4	41.41	0.00	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	50.84	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	50.50	4.22	5.45	1.23	0.26
Skeletal Muscle Cells, donor2	11358-117H8	70.84	2.17	2.17	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	127.08	3.34	0.00	5.02	0.00
Skeletal Muscle Cells, donor4	11451-119A2	105.88	1.73	0.94	1.10	0.63
Skeletal Muscle Cells, donor5	11455-119A6	100.48	1.19	0.89	0.89	0.59
Skeletal Muscle Cells, donor6	11459-119B1	96.65	0.46	0.62	1.54	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	65.78	4.41	2.14	0.38	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	78.62	2.43	1.71	0.86	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	82.44	0.79	0.89	1.29	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	53.25	2.53	3.03	1.01	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	88.30	2.90	0.72	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	103.20	1.51	0.96	2.34	0.69
Skin - palm, donor1	10286-104F7	61.78	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	30.13	0.86	0.29	0.14	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	57.25	1.64	0.82	0.00	7.36
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	39.86	0.78	0.26	0.65	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	21.69	1.25	0.70	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	34.46	0.00	0.14	0.56	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	34.47	0.63	0.21	0.63	10.78
Small Airway Epithelial Cells, donor3	11406-118E2	25.33	0.15	0.30	0.30	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	87.33	1.85	3.70	2.16	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.79	2.00	0.44	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	42.32	1.76	1.76	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	28.07	1.55	0.44	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	61.82	1.97	1.18	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	53.31	3.86	2.32	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	82.06	1.00	4.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	48.97	2.40	1.33	0.80	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	59.85	2.22	1.55	2.22	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	68.37	1.79	1.92	0.38	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	47.86	1.95	0.65	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	45.18	1.77	1.48	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	39.15	0.85	0.28	0.28	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	81.17	1.46	1.95	1.79	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	61.80	1.52	2.13	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	60.36	5.05	3.03	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	52.45	0.95	0.00	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	43.21	2.06	1.47	0.59	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	62.85	0.22	1.51	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	68.43	1.99	1.15	0.94	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	56.30	2.17	2.01	0.62	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	121.80	4.31	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	60.37	0.30	0.30	0.60	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	97.64	2.05	0.68	1.37	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	46.25	3.14	2.67	1.57	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	37.54	2.72	1.01	0.81	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	36.86	2.50	1.14	0.91	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	65.82	1.81	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	75.77	2.91	0.79	0.53	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	42.88	2.66	2.00	0.27	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	72.38	3.26	2.13	1.25	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.56	5.07	2.79	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	52.62	2.26	2.11	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	85.52	1.50	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	62.03	1.29	1.29	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	48.83	3.72	2.79	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	54.02	1.51	1.01	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	54.53	2.19	0.94	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	75.52	2.36	0.88	1.77	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	62.48	0.67	0.83	1.83	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	66.80	3.27	1.87	1.87	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	45.77	1.58	1.01	0.29	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	73.68	1.78	1.27	1.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	90.82	1.32	0.94	0.94	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	57.43	1.12	1.40	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	43.90	1.51	1.42	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	70.95	1.90	1.43	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	33.76	0.49	0.49	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	53.25	3.31	2.65	2.21	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	65.54	2.34	1.76	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	29.93	3.50	1.94	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	42.31	2.38	1.32	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	64.72	8.55	2.60	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	46.00	3.23	1.80	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	53.09	0.85	0.57	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	69.71	2.76	0.39	2.36	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	42.66	7.87	4.06	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	39.53	5.19	2.00	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	48.49	3.76	5.85	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	48.13	4.13	3.21	0.92	1.38
Synoviocyte, donor1	11291-117A4	28.45	2.02	2.36	0.67	0.00
Synoviocyte, donor2	11368-117I9	56.32	4.19	3.35	0.34	0.34
Synoviocyte, donor3	11440-118H9	67.47	4.92	3.35	1.34	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	102.91	2.50	1.79	3.93	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	109.01	3.96	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	106.28	1.85	1.85	1.62	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	44.87	1.43	1.51	0.86	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	61.08	1.16	0.39	1.55	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	54.40	0.00	0.57	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	65.82	2.34	0.98	1.72	0.25
Urethra, donor2	10319-105A4	84.53	1.80	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	40.38	2.13	1.33	0.27	0.00
Urothelial Cells, donor2	11600-120H7	54.08	0.80	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	46.30	0.46	0.46	0.69	0.00
Urothelial cells, donor0	11216-116B1	35.44	2.01	1.34	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	53.39	0.89	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	52.90	1.43	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	39.02	0.00	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	38.57	0.34	1.38	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.67	0.58	1.74	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	30.20	2.08	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	50.48	0.00	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	35.60	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	95.36	2.22	1.73	3.08	0.62
Wilms' tumor cell line:HFWT	10597-108E3	86.24	0.88	0.88	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	77.93	0.28	1.40	1.40	0.00
achilles tendon, donor2	10292-104G4	45.46	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	112.18	4.33	3.57	0.76	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	65.24	5.11	5.34	0.70	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	66.60	3.09	2.14	1.66	1.78
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	82.45	5.71	1.09	1.63	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	100.35	1.97	3.94	1.69	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	67.67	4.23	5.08	2.96	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	106.71	9.53	10.07	1.91	3.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	69.62	2.64	3.97	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	143.33	8.98	4.49	4.08	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	219.39	5.05	4.27	2.33	23.69
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	107.64	3.50	2.02	3.13	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	78.01	0.00	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	106.43	1.39	2.79	3.02	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	126.34	3.37	2.85	0.52	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	115.73	2.05	3.80	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	93.42	0.46	1.86	4.18	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	75.26	2.06	1.65	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	67.84	2.76	1.53	1.53	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	93.02	3.41	4.69	1.71	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	76.13	4.85	3.03	1.21	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	80.88	5.30	3.13	1.68	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	100.90	1.11	1.11	0.22	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	195.46	1.33	2.67	4.34	10.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	263.86	1.86	3.72	13.01	7.43
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	142.38	0.75	2.64	1.88	3.01
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	81.56	6.54	3.93	2.18	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	243.68	0.00	5.62	3.75	11.25
adenocarcinoma cell line:IM95m	10796-110I4	157.08	4.47	0.94	2.59	2.35
adipose tissue, adult, pool1	10010-101C1	38.62	1.24	1.09	0.62	0.00
adipose, donor1	10184-103D4	83.86	5.86	7.04	0.00	1.76
adipose, donor2	10185-103D5	87.19	6.49	1.62	1.22	0.81
adipose, donor3	10186-103D6	85.50	9.26	3.54	1.63	0.27
adipose, donor4	10187-103D7	56.34	2.60	0.87	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	112.68	2.68	1.58	2.53	0.63
adrenal gland, adult, pool1	10081-102A9	207.35	3.64	3.64	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	44.96	3.74	1.07	1.33	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	58.95	2.50	1.07	0.71	0.36
amniotic membrane cells, donor1	12235-129G3	32.46	2.78	0.93	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	48.69	3.72	2.70	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	46.55	4.42	1.77	1.77	0.00
amygdala - adult, donor10196	10167-103B5	78.26	9.49	4.74	1.19	0.00
amygdala, adult, donor10252	10151-102I7	92.06	6.49	2.43	1.82	0.61
amygdala, newborn, donor10223	10360-105E9	66.81	5.16	2.90	2.26	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	53.99	4.20	4.33	0.76	1.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	145.83	5.96	2.87	1.99	1.76
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	88.85	2.34	3.34	1.34	1.00
aorta, adult, pool1	10052-101G7	67.67	2.35	1.37	0.98	0.78
appendix, adult	10189-103D9	86.16	2.33	2.72	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	100.43	8.60	5.16	1.38	2.06
artery, adult	10190-103E1	137.23	2.72	0.00	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	62.00	6.08	7.39	1.74	1.01
b cell line:RPMI1788	10427-106D4	93.38	5.95	5.20	2.23	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	46.61	4.16	3.05	0.00	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	35.82	1.09	0.60	1.09	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	41.34	4.52	2.18	0.50	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	100.10	3.36	1.68	1.12	0.56
bladder, adult, pool1	10011-101C2	36.07	2.06	1.20	0.43	0.54
blood, adult, pool1	10053-101G8	57.58	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	35.97	3.43	0.00	0.86	0.00
bone marrow, adult	10192-103E3	60.73	2.02	2.02	1.35	0.00
brain, adult, donor1	10084-102B3	104.56	2.05	8.20	3.08	0.00
brain, adult, pool1	10012-101C3	61.47	4.45	3.23	1.67	0.11
brain, fetal, pool1	10085-102B4	141.58	2.67	2.67	10.69	0.00
breast carcinoma cell line:MCF7	10482-107A5	118.93	0.99	1.32	1.98	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	70.28	13.98	4.12	2.50	3.00
breast, adult, donor1	10080-102A8	89.02	0.63	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	113.70	1.65	0.51	3.43	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	80.71	4.02	4.02	1.24	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	60.78	2.30	1.61	1.38	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	81.83	5.33	2.42	1.21	0.00
carcinoid cell line:NCI-H1770	10703-109H1	69.58	2.35	1.88	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	43.42	0.33	0.55	0.77	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	93.17	3.49	6.97	1.90	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	104.61	11.45	8.78	0.80	0.80
caudate nucleus - adult, donor10196	10177-103C6	100.17	4.61	1.15	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	87.18	4.35	3.35	2.34	0.67
caudate nucleus, adult, donor10258	10379-105H1	77.94	3.06	3.82	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	72.15	4.03	4.03	2.93	0.37
cerebellum - adult, donor10196	10173-103C2	154.40	8.74	2.91	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	88.39	2.56	0.43	1.28	1.07
cerebellum, adult, pool1	10083-102B2	111.42	3.79	0.69	2.41	0.00
cerebellum, newborn, donor10223	10357-105E6	78.05	8.30	4.15	1.66	0.00
cerebral meninges, adult	10188-103D8	86.23	3.53	2.77	4.29	0.00
cerebrospinal fluid, donor2	10294-104G6	109.63	1.46	0.00	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	54.64	6.90	4.46	1.87	0.58
cervical cancer cell line:ME-180	10553-107I4	37.12	1.99	2.49	0.50	0.66
cervix, adult, pool1	10013-101C4	46.72	5.25	2.31	0.94	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	24.94	1.53	0.70	0.28	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	49.64	2.61	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	48.47	3.36	2.36	2.49	0.37
choriocarcinoma cell line:SCH	10785-110H2	98.57	5.05	4.44	2.59	1.85
choriocarcinoma cell line:T3M-3	10618-108G6	102.22	2.37	1.42	4.98	1.19
chorionic membrane cells, donor1	12238-129G6	31.34	2.28	0.28	1.42	0.28
chorionic membrane cells, donor2	12239-129G7	30.03	1.39	1.19	0.89	0.50
chorionic membrane cells, donor3	12240-129G8	46.71	1.65	3.30	1.10	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	86.84	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	143.31	2.69	2.11	2.88	4.03
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	152.27	3.17	3.59	2.53	3.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	97.58	2.82	1.54	1.80	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	97.24	1.69	1.69	1.94	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	83.89	3.05	2.24	1.22	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	96.88	2.65	2.36	2.36	8.54
chronic myelogenous leukemia cell line:KU812	10409-106B4	101.64	5.47	8.08	1.82	5.99
clear cell carcinoma cell line:JHOC-5	10638-108I8	86.40	1.37	0.91	1.83	0.46
clear cell carcinoma cell line:TEN	10636-108I6	27.41	0.52	0.87	0.87	0.35
colon carcinoma cell line:CACO-2	10513-107D9	63.52	1.83	1.65	1.46	0.55
colon carcinoma cell line:COLO-320	10420-106C6	66.13	8.36	5.70	1.90	0.38
colon, adult, donor1	10082-102B1	141.61	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	67.56	3.41	1.65	0.82	0.35
colon, fetal, donor1	10070-101I7	109.38	3.09	0.62	3.71	0.00
common myeloid progenitor CMP, donor1	12130-128D6	27.50	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	62.04	6.37	2.12	1.27	2.97
cord blood derived cell line:COBL-a 24h infection	10453-106G3	70.03	4.98	1.81	1.36	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	70.51	5.92	2.12	1.69	3.10
corpus callosum, adult, pool1	10042-101F6	73.30	6.19	1.44	2.21	0.55
cruciate ligament, donor2	10295-104G7	68.08	1.62	1.62	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	200.64	4.01	0.00	9.63	0.80
diencephalon, adult	10193-103E4	83.76	3.60	1.44	1.44	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	115.04	2.53	2.30	2.53	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	45.90	1.54	2.82	2.56	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	35.63	1.20	6.74	0.72	0.96
ductus deferens, adult	10196-103E7	67.77	3.99	1.50	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	126.74	8.64	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	85.34	2.94	4.41	1.47	0.00
dura mater, adult, donor1	10041-101F5	43.69	7.19	2.97	0.74	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	73.73	4.44	4.66	2.66	2.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	76.52	4.59	2.87	1.43	1.43
embryonic pancreas cell line:1B2C6	10604-108F1	60.43	2.47	1.85	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	37.23	3.63	0.61	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	55.57	2.47	3.40	3.09	0.00
embryonic pancreas cell line:2C6	10603-108E9	53.85	2.63	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	29.83	11.40	9.39	1.01	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	44.95	7.25	5.07	1.81	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	78.80	2.41	1.29	0.16	0.48
epidermoid carcinoma cell line:A431	10426-106D3	47.91	3.89	2.00	1.11	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	30.69	1.21	0.66	0.22	0.55
epididymis, adult	10197-103E8	54.00	3.77	1.26	2.09	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.95	1.24	0.89	0.35	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	19.66	0.39	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	64.74	3.67	1.18	2.62	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	55.21	4.53	1.28	1.87	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	62.74	3.81	1.12	2.69	0.90
esophagus, adult, pool1	10015-101C6	48.52	1.81	1.17	0.42	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	75.89	16.03	11.27	1.75	1.13
eye - muscle inferior rectus, donor1	10272-104E2	103.83	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	174.65	0.00	2.10	0.00	2.10
eye - muscle medial, donor2	10299-104H2	172.63	0.00	0.00	5.95	0.00
eye - muscle superior, donor2	10297-104G9	135.29	1.15	0.00	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	48.09	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	113.13	7.12	3.56	2.54	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	72.83	1.92	1.41	0.51	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	84.28	1.19	0.47	2.37	1.19
frontal lobe, adult, pool1	10040-101F4	67.83	7.41	2.53	0.94	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	38.13	8.41	1.50	3.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	22.86	1.37	1.10	0.00	0.27
gall bladder, adult	10198-103E9	72.67	2.90	1.21	2.17	0.24
gamma delta positive T cells, donor1	11937-126A2	53.69	1.61	1.61	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	41.46	2.24	0.75	0.00	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	33.58	1.27	0.63	0.63	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	54.93	1.55	1.35	0.58	0.58
gastric cancer cell line:AZ521	10549-107H9	73.45	4.59	1.64	2.62	0.33
gastric cancer cell line:GSS	10560-108A2	63.15	3.66	0.92	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	65.80	4.80	5.03	1.37	1.14
giant cell carcinoma cell line:LU65	10487-107B1	21.80	1.03	0.57	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	37.23	3.78	2.38	1.82	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	77.82	4.99	0.75	3.24	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	22.48	1.37	0.21	0.21	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	23.31	1.12	0.28	0.42	0.70
glioblastoma cell line:T98G	10485-107A8	52.54	2.54	1.77	1.10	0.22
glioma cell line:GI-1	10413-106B8	36.61	3.81	2.34	0.59	0.88
globus pallidus - adult, donor10196	10175-103C4	144.32	4.37	2.19	2.19	0.73
globus pallidus, adult, donor10252	10161-103A8	86.65	4.64	0.98	0.73	0.98
globus pallidus, adult, donor10258	10367-105F7	153.35	0.00	4.11	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	57.56	3.73	1.60	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	61.18	0.00	0.00	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	10.45	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	33.92	0.00	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	72.54	0.46	1.38	1.84	0.00
hIPS +CCl2, biol_rep2	14384-156C1	61.27	0.91	0.46	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	83.73	2.58	1.29	1.29	0.00
hIPS, biol_rep1	14380-156B6	130.79	1.44	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	78.19	0.00	2.06	0.00	0.00
hIPS, biol_rep3	14382-156B8	123.59	7.72	2.21	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	117.24	2.87	2.59	0.86	2.87
heart - mitral valve, adult	10205-103F7	58.60	1.49	1.20	2.39	0.30
heart - pulmonic valve, adult	10206-103F8	94.65	2.88	0.26	4.45	1.05
heart - tricuspid valve, adult	10207-103F9	49.96	0.83	0.00	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	112.03	2.45	0.82	2.65	0.20
heart, adult, diseased, donor1	10051-101G6	188.22	1.70	1.70	3.41	0.00
heart, adult, pool1	10016-101C7	79.57	0.00	0.23	2.53	0.23
heart, fetal, pool1	10046-101G1	80.81	1.75	1.64	1.85	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	48.44	0.31	0.31	0.93	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	68.97	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	89.06	4.64	3.20	2.21	1.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	92.24	4.85	4.49	3.03	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	88.42	4.55	3.74	2.02	1.31
hepatoma cell line:Li-7	10484-107A7	36.92	2.67	2.22	0.78	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	120.90	3.32	2.61	0.70	1.21
hippocampus - adult, donor10196	10169-103B7	87.06	2.84	2.84	5.68	0.00
hippocampus, adult, donor10252	10153-102I9	89.19	4.29	2.45	2.04	1.02
hippocampus, adult, donor10258	10374-105G5	93.61	2.49	1.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	48.99	2.11	1.06	2.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	95.82	1.22	3.66	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	64.40	1.57	0.98	2.55	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	57.89	0.76	1.27	1.78	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	85.71	3.95	2.26	2.82	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	97.09	5.42	2.58	3.36	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	72.89	3.04	2.66	3.04	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	88.75	9.93	3.21	3.80	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	76.48	7.97	3.66	2.37	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	74.66	7.51	2.92	3.34	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	68.67	8.52	4.74	2.37	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	95.14	6.75	2.89	2.73	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	54.54	10.77	3.37	4.04	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	51.17	1.25	0.47	0.94	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	68.29	1.47	0.49	0.00	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	61.09	4.36	1.75	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	99.46	4.01	3.63	1.53	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	105.09	2.18	3.05	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	97.95	7.00	4.00	4.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	80.07	10.36	4.90	2.07	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	90.94	9.09	3.18	2.73	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	71.42	11.28	5.64	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	75.12	11.43	4.57	1.63	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	72.58	9.00	4.06	2.03	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	79.51	9.27	5.38	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	67.99	1.66	0.74	0.74	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	68.75	1.43	2.85	1.14	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	68.19	2.86	0.82	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	97.53	4.22	4.93	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	76.33	5.38	1.90	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	81.10	8.78	3.63	2.12	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	81.71	8.27	4.14	3.10	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	79.70	6.64	6.64	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	59.77	8.21	4.62	1.03	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	87.18	8.69	4.86	1.28	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	91.62	11.36	4.54	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	66.54	14.45	7.39	2.02	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	63.03	2.42	0.72	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	53.48	1.34	2.23	1.78	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	66.83	4.39	1.95	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	74.88	6.42	2.14	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	107.36	13.01	16.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	82.74	7.28	4.63	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	84.83	8.21	4.93	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	69.84	10.49	5.79	1.45	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	74.02	6.76	4.63	2.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	81.15	4.77	0.00	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	65.00	13.27	5.82	1.22	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	57.38	6.47	5.39	2.69	0.27
immature langerhans cells, donor1	11904-125F5	19.37	4.12	2.66	0.73	0.24
immature langerhans cells, donor2	11905-125F6	32.48	2.38	0.00	1.58	2.38
insula, adult, pool1	10039-101F3	70.88	9.65	3.69	1.80	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	144.37	3.58	0.33	0.65	1.30
kidney, adult, pool1	10017-101C8	68.09	3.20	0.90	1.90	0.60
kidney, fetal, pool1	10045-101F9	74.77	5.02	2.62	1.06	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	16.47	1.28	2.27	0.00	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	36.63	4.29	1.80	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.70	0.73	1.47	0.92	0.00
left atrium, adult, donor1	10079-102A7	130.76	1.63	0.54	9.81	0.00
left ventricle, adult, donor1	10078-102A6	158.78	0.51	0.00	6.57	0.00
leiomyoblastoma cell line:G-402	10721-110A1	114.64	0.82	1.37	2.74	0.55
leiomyoma cell line:10964C	10569-108B2	68.98	2.87	0.00	2.51	0.36
leiomyoma cell line:15242A	10570-108B3	36.96	1.09	1.09	0.54	0.54
leiomyoma cell line:15425	10571-108B4	64.59	1.46	0.73	1.70	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	6.35	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	4.18	0.00	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	112.75	5.31	21.84	1.65	2.72
liposarcoma cell line:KMLS-1	10782-110G8	75.76	0.62	1.09	1.56	4.06
liposarcoma cell line:SW 872	10726-110A6	51.42	2.07	1.83	1.71	0.12
liver, adult, pool1	10018-101C9	87.03	2.43	0.81	0.65	0.32
liver, fetal, pool1	10086-102B5	127.94	0.94	0.00	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	104.70	2.92	0.73	3.79	0.58
locus coeruleus, adult, donor10252	10165-103B3	74.19	6.64	2.77	1.85	1.11
locus coeruleus, adult, donor10258	10375-105G6	110.32	6.49	3.39	1.13	0.28
locus coeruleus, newborn, donor10223	10362-105F2	71.51	6.73	3.36	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	24.63	1.94	1.38	1.52	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	44.81	7.58	3.45	4.14	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	50.22	3.69	1.85	0.79	0.40
lung, adult, pool1	10019-101D1	35.08	1.42	2.13	0.12	0.71
lung, fetal, donor1	10068-101I5	65.64	7.42	5.42	1.43	0.00
lung, right lower lobe, adult, donor1	10075-102A3	92.10	2.29	0.92	0.92	0.46
lymph node, adult, donor1	10077-102A5	74.32	2.37	2.37	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	101.70	3.07	3.29	1.75	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	79.99	2.87	1.36	2.57	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	95.99	5.95	1.70	2.55	3.40
mature adipocyte, donor1	12231-129F8	53.28	0.44	0.44	1.78	0.44
mature adipocyte, donor2	12232-129F9	47.94	0.42	0.42	1.25	0.00
mature adipocyte, donor3	12233-129G1	56.66	1.42	0.00	1.90	0.00
mature adipocyte, donor4	12234-129G2	51.33	1.58	0.26	0.53	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	33.36	3.57	1.19	0.48	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	106.03	5.64	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	79.82	5.89	1.84	1.47	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	111.19	5.72	1.59	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	57.58	8.96	3.84	2.56	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	107.33	6.24	3.88	4.05	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	92.95	4.24	1.27	1.49	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	100.17	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	66.76	3.95	1.44	2.87	0.00
medulla oblongata - adult, donor10196	10174-103C3	116.82	4.54	1.30	3.89	0.00
medulla oblongata, adult, donor10252	10155-103A2	72.60	4.18	1.39	2.63	0.77
medulla oblongata, adult, pool1	10038-101F2	60.65	7.18	3.43	1.06	0.41
medulla oblongata, newborn, donor10223	10361-105F1	53.12	5.55	0.69	1.74	0.69
medulloblastoma cell line:D283 Med	10838-111E1	58.67	7.75	7.31	0.89	0.44
medulloblastoma cell line:ONS-76	10759-110E3	52.21	0.49	0.49	1.71	0.61
melanoma cell line:COLO 679	10514-107E1	50.74	4.02	1.58	2.30	1.29
melanoma cell line:G-361	10465-106H6	31.49	5.16	2.44	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	27.86	0.90	0.54	1.09	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	118.96	5.29	2.64	7.05	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	88.40	7.78	2.59	2.33	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	84.24	1.38	1.69	0.61	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	44.90	3.27	2.91	0.00	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	66.26	2.48	2.90	2.90	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	50.43	2.39	1.97	0.56	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	59.12	3.66	1.54	0.58	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	47.89	3.47	2.78	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	39.65	3.43	2.92	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	50.15	1.96	1.61	0.35	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	68.04	1.46	1.19	0.13	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	46.72	2.16	0.27	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	36.28	0.28	0.14	1.00	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	32.28	3.62	1.98	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	45.94	1.66	0.69	0.42	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	46.43	3.14	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	40.63	1.22	1.43	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.27	1.44	0.36	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	40.66	2.69	0.62	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	22.34	0.91	1.14	0.23	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	54.96	1.26	1.68	0.42	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	43.64	0.90	0.15	0.75	1.20
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	43.68	1.23	0.70	0.26	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	36.08	3.31	1.47	0.00	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.18	0.57	0.29	0.00	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	49.68	1.26	0.84	0.42	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	89.05	1.37	1.37	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	64.71	4.35	2.81	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	68.06	1.57	2.36	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	60.38	2.16	0.00	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	61.66	4.00	2.35	1.18	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	63.97	3.05	2.03	1.02	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	56.98	2.36	2.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	53.75	1.39	1.39	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	89.70	4.04	3.46	1.15	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	70.72	3.79	2.23	0.67	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	73.79	1.68	2.88	0.72	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	61.60	0.73	4.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	57.73	3.36	1.68	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	64.27	2.46	2.46	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	73.45	3.01	3.44	0.86	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	62.89	0.00	8.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	82.64	5.16	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	67.88	2.92	2.27	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	59.65	7.27	5.82	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	85.29	2.67	1.07	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	60.52	4.09	1.64	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	55.20	1.94	1.55	1.17	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	58.76	6.30	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	52.65	4.97	3.97	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	90.58	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	64.04	3.56	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	70.67	1.22	3.66	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	58.90	1.90	1.90	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	60.70	4.14	4.14	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	53.73	6.45	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	7.98	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	68.88	13.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	60.31	5.70	2.44	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	56.41	7.94	7.15	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	48.34	6.48	5.90	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	48.94	4.68	6.86	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	61.49	8.02	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	86.34	3.55	4.73	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	89.88	2.57	2.57	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	82.61	3.44	1.38	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	125.68	0.99	1.48	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	100.94	1.12	2.24	4.49	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	116.40	3.18	2.54	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	134.19	0.81	1.61	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	150.46	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	131.77	5.07	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	89.21	5.46	0.00	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	103.94	4.52	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	96.37	4.12	0.82	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	59.33	3.37	2.98	0.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	80.80	3.24	3.57	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	64.17	6.11	2.04	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	15.47	2.32	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	28.59	2.60	1.89	0.47	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	36.84	10.19	6.02	0.93	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.01	2.06	1.54	0.21	0.72
mesothelioma cell line:Mero-25	10850-111F4	48.11	1.36	1.13	0.23	1.36
mesothelioma cell line:Mero-41	10851-111F5	33.74	1.47	0.49	0.73	0.24
mesothelioma cell line:Mero-48a	10852-111F6	37.42	0.89	0.44	0.00	0.66
mesothelioma cell line:Mero-82	10853-111F7	40.21	0.79	5.26	1.58	0.53
mesothelioma cell line:Mero-83	10854-111F8	25.19	0.68	0.68	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	34.88	0.76	0.25	1.01	0.25
mesothelioma cell line:Mero-95	10856-111G1	33.13	2.07	0.62	1.04	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	48.70	0.99	0.50	1.49	0.33
mesothelioma cell line:NCI-H226	10846-111E9	20.81	0.00	0.00	0.18	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	39.80	1.02	0.51	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	82.70	3.82	2.29	2.29	0.51
mesothelioma cell line:No36	10857-111G2	45.02	0.65	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	29.80	1.90	0.54	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	27.83	0.58	1.73	0.38	0.00
migratory langerhans cells, donor2	11902-125F3	17.22	0.73	0.85	0.98	0.00
migratory langerhans cells, donor3	11903-125F4	32.84	2.69	2.69	1.08	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	36.89	1.63	1.31	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	42.39	2.54	2.54	2.12	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	77.63	1.84	0.92	1.38	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	103.71	1.14	1.52	2.28	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	96.65	7.39	4.25	2.40	2.22
myeloma cell line:PCM6	10474-106I6	74.32	9.29	8.50	0.99	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	80.15	2.54	1.52	3.04	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	52.17	1.37	1.18	0.59	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	35.21	0.78	1.67	0.67	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.25	2.50	1.25	0.37	0.29
nasal epithelial cells, donor2	12227-129F4	28.15	1.66	2.21	0.55	1.66
neuroblastoma cell line:CHP-134	10508-107D4	62.12	8.74	7.82	1.15	0.23
neuroblastoma cell line:NB-1	10539-107G8	81.76	5.24	4.30	1.87	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	57.99	4.43	8.86	0.63	1.90
neuroblastoma cell line:NH-12	10555-107I6	101.00	6.71	4.66	1.68	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	103.90	8.07	4.74	0.24	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	108.81	3.01	3.17	2.38	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	150.74	6.04	15.09	3.02	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	131.60	6.99	5.09	3.18	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	67.34	2.40	1.60	0.80	0.80
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	48.20	5.41	4.57	1.18	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	57.64	3.20	0.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	82.40	7.37	6.41	1.28	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	40.99	1.05	3.15	1.05	0.26
nucleus accumbens, adult, pool1	10037-101F1	71.43	6.75	3.28	0.84	0.75
occipital cortex - adult, donor10196	10172-103C1	160.71	6.18	4.12	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	80.78	3.76	1.07	1.88	0.27
occipital cortex, newborn, donor10223	10355-105E4	53.50	3.28	1.09	2.18	0.00
occipital lobe, adult, donor1	10076-102A4	144.58	5.25	3.67	2.10	0.00
occipital lobe, fetal, donor1	10073-102A1	159.63	7.72	3.86	2.57	0.00
occipital pole, adult, pool1	10036-101E9	69.77	3.94	2.29	1.73	0.16
olfactory region, adult	10195-103E6	86.55	5.16	1.15	0.57	0.19
optic nerve, donor1	10277-104E7	110.06	2.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	33.03	6.15	4.33	0.91	1.48
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	49.32	2.34	1.51	1.92	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	34.20	1.52	1.69	1.35	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	44.82	1.27	1.85	0.58	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	39.98	2.06	0.00	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	16.82	2.80	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	58.32	5.51	4.88	1.91	2.54
ovary, adult, pool1	10020-101D2	44.90	7.42	6.46	1.48	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	89.28	1.28	1.83	0.73	1.65
pancreas, adult, donor1	10049-101G4	127.93	0.94	1.88	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	44.45	0.28	0.28	1.12	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	41.91	2.38	1.02	0.68	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	29.80	2.65	1.66	0.33	0.33
paracentral gyrus, adult, pool1	10035-101E8	69.74	5.31	2.11	1.46	0.09
parietal cortex, adult, donor10258	10373-105G4	85.88	2.94	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	101.57	6.58	1.88	5.64	1.88
parietal lobe, adult, donor10252	10157-103A4	86.08	3.71	0.57	1.14	0.57
parietal lobe, adult, pool1	10034-101E7	69.44	6.17	2.20	0.97	0.35
parietal lobe, fetal, donor1	10072-101I9	126.08	9.70	4.85	2.91	0.97
parietal lobe, newborn, donor10223	10356-105E5	45.61	2.62	0.37	3.74	0.37
parotid gland, adult	10199-103F1	69.68	0.62	0.62	3.08	0.00
penis, adult	10200-103F2	63.92	3.22	0.54	2.69	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	93.90	4.09	3.53	2.23	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	68.48	1.60	1.75	0.15	0.87
pineal gland - adult, donor10196	10179-103C8	133.52	1.29	0.00	6.45	1.29
pineal gland, adult, donor10252	10160-103A7	66.33	7.11	2.96	1.78	2.96
pineal gland, adult, donor10258	10377-105G8	104.72	3.76	1.25	1.25	0.63
pituitary gland - adult, donor10196	10180-103C9	55.65	6.07	3.04	3.04	2.02
pituitary gland, adult, donor10252	10162-103A9	46.38	9.38	5.73	1.56	0.52
pituitary gland, adult, donor10258	10378-105G9	60.44	5.96	4.26	0.00	1.70
placenta, adult, pool1	10021-101D3	40.53	1.08	1.61	0.75	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	74.95	2.52	1.06	2.78	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	25.52	2.33	0.78	0.47	0.16
pons, adult, pool1	10033-101E6	51.98	3.27	1.03	1.20	0.26
postcentral gyrus, adult, pool1	10032-101E5	73.75	6.28	2.62	2.01	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	2.09	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	77.11	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	36.85	1.02	0.87	1.31	1.46
prostate cancer cell line:PC-3	10439-106E7	48.10	7.80	3.45	0.54	1.09
prostate, adult, pool1	10022-101D4	45.62	3.63	1.00	0.45	0.09
putamen, adult, donor10196	10176-103C5	107.88	7.32	3.30	3.78	1.18
putamen, adult, donor10252	10152-102I8	43.14	5.88	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	76.50	3.28	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	77.80	3.38	1.21	0.72	0.24
putamen, newborn, donor10223	10365-105F5	74.22	6.75	5.25	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	19.78	3.20	2.33	0.29	0.29
rectum, fetal, donor1	10067-101I4	190.57	1.39	4.17	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	55.76	1.06	0.00	1.06	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	11.60	0.41	0.00	0.41	0.41
retina, adult, pool1	10030-101E3	76.74	8.15	3.38	1.89	0.10
retinoblastoma cell line:Y79	10475-106I7	47.54	1.56	2.86	1.56	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	74.63	0.61	0.61	2.83	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	55.96	5.62	5.06	1.97	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	56.08	3.03	0.76	3.03	0.00
salivary acinar cells, donor1	11771-123I7	49.04	4.05	3.08	0.81	0.65
salivary acinar cells, donor2	11772-123I8	53.42	4.54	3.30	1.10	0.55
salivary acinar cells, donor3	11773-123I9	72.16	1.99	1.99	4.63	0.66
salivary gland, adult, pool1	10093-102C3	85.22	3.43	1.72	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.26	1.26	0.51	0.42	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	25.04	0.71	0.82	0.47	0.71
seminal vesicle, adult	10201-103F3	75.66	3.17	2.12	1.59	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	40.81	2.19	1.21	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.92	0.25	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	41.14	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	100.20	3.36	5.51	2.82	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	54.60	1.66	1.11	3.21	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	52.13	2.84	1.16	1.68	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	194.36	1.42	0.00	4.97	0.00
skeletal muscle, adult, pool1	10023-101D5	83.00	0.48	0.12	2.76	0.24
skeletal muscle, fetal, donor1	10066-101I3	201.00	1.01	4.02	0.00	1.01
skin, adult, donor1	10074-102A2	88.21	0.00	0.00	13.57	0.00
skin, fetal, donor1	10065-101I2	149.60	4.42	2.52	3.16	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	81.05	5.67	2.00	3.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	51.38	5.67	7.25	1.26	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	68.62	1.54	0.96	0.77	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	44.83	8.57	3.96	1.32	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	55.81	0.16	0.00	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	49.47	2.18	2.83	2.18	0.22
small intestine, adult, pool1	10024-101D6	94.96	2.51	0.60	2.51	0.48
small intestine, fetal, donor1	10064-101I1	124.81	3.69	3.44	3.44	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	59.50	1.54	1.54	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	63.58	0.26	0.00	1.29	0.00
somatostatinoma cell line:QGP-1	10781-110G7	54.94	1.34	2.41	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	132.83	6.42	2.52	2.06	0.46
spinal cord, adult, donor10252	10159-103A6	57.56	3.15	3.94	2.76	0.79
spinal cord, adult, donor10258	10369-105F9	151.50	6.92	1.38	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	154.29	6.71	1.22	5.49	1.22
spinal cord, newborn, donor10223	10359-105E8	89.09	5.97	3.67	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	50.93	0.90	1.64	1.19	0.30
spleen, adult, pool1	10025-101D7	34.80	1.21	1.21	0.77	2.09
spleen, fetal, pool1	10044-101F8	44.97	1.11	1.67	0.32	2.07
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	57.86	3.31	2.38	1.66	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	32.47	3.42	2.28	1.14	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	68.84	2.45	1.75	0.70	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	69.59	0.78	1.56	1.56	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	48.96	2.36	0.90	1.91	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	55.07	5.08	3.81	4.24	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	32.58	3.81	2.12	2.54	1.27
stomach, fetal, donor1	10062-101H8	217.87	4.27	3.20	6.41	2.14
submaxillary gland, adult	10202-103F4	76.91	0.57	0.57	4.56	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	63.77	4.98	2.08	1.25	1.04
substantia nigra, adult, donor10258	10371-105G2	118.45	2.59	2.59	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	76.31	2.12	1.41	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	49.29	4.81	2.06	1.83	0.69
temporal lobe, adult, pool1	10031-101E4	82.65	8.14	3.73	2.12	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	169.52	11.40	3.56	4.27	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	78.68	10.99	1.76	2.20	0.00
tenocyte, donor1	11763-123H8	81.34	2.44	1.05	0.35	0.35
tenocyte, donor2	11765-123I1	64.47	3.82	1.91	0.00	0.38
tenocyte, donor3	11768-123I4	74.87	2.22	0.74	1.48	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	45.21	2.04	1.53	0.68	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	98.81	2.31	2.77	0.31	0.77
teratocarcinoma cell line:PA-1	10807-111A6	104.15	0.77	1.55	1.86	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	69.44	2.92	1.02	0.63	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	54.08	5.29	4.92	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	41.33	1.53	1.42	0.98	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	36.15	0.98	1.30	1.95	0.00
testis, adult, pool1	10026-101D8	50.04	3.97	2.36	0.64	0.43
testis, adult, pool2	10096-102C6	83.45	4.06	0.90	0.90	0.90
thalamus - adult, donor10196	10168-103B6	152.35	7.73	5.52	4.42	0.00
thalamus, adult, donor10252	10154-103A1	73.61	3.75	1.56	0.94	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	164.74	6.16	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	92.89	3.62	1.48	0.66	0.16
thalamus, newborn, donor10223	10366-105F6	70.76	2.88	1.15	1.73	0.00
throat, adult	10209-103G2	98.87	1.00	1.50	4.49	0.25
throat, fetal, donor1	10061-101H7	152.35	4.27	1.22	4.88	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	116.85	9.94	7.15	4.57	0.79
thymus, adult, pool1	10027-101D9	46.23	1.79	0.99	0.50	0.60
thymus, fetal, pool1	10043-101F7	52.99	1.25	1.04	0.42	2.39
thyroid carcinoma cell line:KHM-5M	10776-110G2	72.06	4.79	0.93	1.33	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	75.15	1.40	0.70	1.82	1.12
thyroid, adult, pool1	10028-101E1	78.57	6.44	2.71	1.68	0.28
thyroid, fetal, donor1	10060-101H6	146.33	2.64	1.58	4.75	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	85.82	1.40	1.16	5.35	0.00
tongue, fetal, donor1	10059-101H5	248.28	0.79	0.79	6.31	0.79
tonsil, adult, pool1	10047-101G2	64.91	3.11	0.80	0.70	0.20
trachea, adult, pool1	10029-101E2	36.89	2.21	1.47	0.41	0.16
trachea, fetal, donor1	10058-101H4	118.87	2.69	0.77	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	85.73	1.42	2.13	2.48	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	39.41	1.62	1.32	1.62	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	31.81	9.40	5.64	0.63	0.31
tridermal teratoma cell line:HGRT	10694-109G1	66.59	0.00	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	70.94	3.47	2.88	1.86	0.08
umbilical cord, fetal, donor1	10057-101H3	79.29	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	53.75	4.44	2.90	0.85	1.19
uterus, fetal, donor1	10055-101H1	117.74	5.63	3.58	2.05	0.51
vagina, adult	10204-103F6	43.94	0.65	1.94	0.00	0.65
vein, adult	10191-103E2	67.95	1.97	1.75	1.32	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	100.67	1.60	2.67	0.27	0.53